A detailed history of Pegasus Partners Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Pegasus Partners Ltd. holds 918 shares of AMGN stock, worth $291,446. This represents 0.03% of its overall portfolio holdings.

Number of Shares
918
Previous 1,042 11.9%
Holding current value
$291,446
Previous $296,000 3.38%
% of portfolio
0.03%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$262.75 - $319.31 $32,581 - $39,594
-124 Reduced 11.9%
918 $286,000
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $233,887 - $263,782
1,042 New
1,042 $235,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $272,554 - $319,330
-1,284 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $7,007 - $7,774
-30 Reduced 2.28%
1,284 $313,000
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $291,589 - $339,800
1,314 New
1,314 $327,000
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $271,902 - $360,616
-1,492 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $157,422 - $202,342
-832 Reduced 35.8%
1,492 $360,000
Q3 2019

Oct 24, 2019

SELL
$174.11 - $208.62 $727,779 - $872,031
-4,180 Reduced 64.27%
2,324 $450,000
Q2 2019

Jul 30, 2019

SELL
$166.7 - $195.41 $257,384 - $301,713
-1,544 Reduced 19.18%
6,504 $1.2 Million
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $81,210 - $91,542
-449 Reduced 5.28%
8,048 $1.53 Million
Q4 2018

Feb 01, 2019

SELL
$178.4 - $208.25 $248,868 - $290,508
-1,395 Reduced 14.1%
8,497 $1.65 Million
Q3 2018

Nov 07, 2018

BUY
$185.29 - $208.89 $97,091 - $109,458
524 Added 5.59%
9,892 $2.05 Million
Q2 2018

Jul 27, 2018

BUY
$166.05 - $186.51 $226,658 - $254,586
1,365 Added 17.06%
9,368 $1.73 Million
Q1 2018

May 09, 2018

SELL
$169.43 - $198.0 $336,826 - $393,624
-1,988 Reduced 19.9%
8,003 $1.36 Million
Q4 2017

Feb 08, 2018

BUY
$168.79 - $188.59 $65,659 - $73,361
389 Added 4.05%
9,991 $1.74 Million
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $1.61 Million - $1.83 Million
9,602
9,602 $1.79 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pegasus Partners Ltd. Portfolio

Follow Pegasus Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Partners Ltd. with notifications on news.